(Total Views: 773)
Posted On: 02/06/2025 6:00:10 PM
Post# of 154722
From doit4dale on Stocktwits. Look at what Emma just said:
Chief Executive Officer (CEO) Emma Walmsley said the company lifted its 2031 estimate as the company is "increasing and prioritizing R&D investment to promising new long-acting and specialty medicines in Respiratory, Immunology & Inflammation, Oncology and HIV.”
https://www.investopedia.com/gsk-stock-jumps-...an-8786250
Looks like we might have a few things in common with GSK and their goals.
Chief Executive Officer (CEO) Emma Walmsley said the company lifted its 2031 estimate as the company is "increasing and prioritizing R&D investment to promising new long-acting and specialty medicines in Respiratory, Immunology & Inflammation, Oncology and HIV.”
https://www.investopedia.com/gsk-stock-jumps-...an-8786250
Looks like we might have a few things in common with GSK and their goals.
(14)
(0)
